Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, ...
Nearly 30 percent of people who took Bharat Biotech’s COVID-19 vaccine – Covaxin – experienced ‘adverse events of special interest’ (AESI), such as stroke and weakness in the nerves of ...
Nearly 50 per cent of the participants complained of infections during the follow-up period, predominated by viral upper respiratory tract infections. A one-year follow-up study conducted by ...
New Delhi: Weeks after AstraZeneca admitted that its COVID vaccine, including Covishield, can cause rare side-effects of blood clotting and lowering of platelet count, a Banaras Hindu University (BHU) ...
Covaxin Vaccine Side Effects: In an observational study on Bharat Biotech's Covaxin, nearly a third of participants reported adverse events of special interest (AESI), with females and those with ...
In light of growing concerns about COVID-19 vaccine safety, a comprehensive one-year follow-up study by Banaras Hindu University (BHU) researchers sheds light on the long-term effects of Bharat ...
Covaxin, the Covid-19 vaccine developed by Bharat Biotech, has caused several adverse side effects in recipients, including respiratory tract infections and menstrual abnormalities, a new study ...
Among the 926 participants, which included 635 adolescents and 291 adults, new-onset skin and subcutaneous disorders, general disorders, and nervous system disorders were identified as the most ...
Adolescent girls and those with comorbidities are at a higher risk of adverse events after receiving Bharat Biotech’s BBV152 (Covaxin) vaccine against COVID-19, according to a report published ...
1 in 3 Covaxin recipients hit by adverse events: Study One-third of Covaxin recipients experienced adverse events of special interest within a year, including upper respiratory tract infections and ...